| The immune landscape of cancer V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ... Immunity 48 (4), 812-830. e14, 2018 | 4752 | 2018 |
| An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics J Liu, T Lichtenberg, KA Hoadley, LM Poisson, AJ Lazar, AD Cherniack, ... Cell 173 (2), 400-416. e11, 2018 | 2850 | 2018 |
| Oncogenic signaling pathways in the cancer genome atlas F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ... Cell 173 (2), 321-337. e10, 2018 | 2667 | 2018 |
| Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. N Weidner, PR Carroll, J Flax, W Blumenfeld, J Folkman The American journal of pathology 143 (2), 401, 1993 | 2389 | 1993 |
| Comprehensive characterization of cancer driver genes and mutations MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ... Cell 173 (2), 371-385. e18, 2018 | 2293 | 2018 |
| Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer KA Hoadley, C Yau, T Hinoue, DM Wolf, AJ Lazar, E Drill, R Shen, ... Cell 173 (2), 291-304. e6, 2018 | 2151 | 2018 |
| Carcinoma-associated fibroblasts stimulate tumor progression of initiated human epithelium AF Olumi, GD Grossfeld, SW Hayward, PR Carroll, GR Cunha, P Hein, ... Breast Cancer Research 2, 1-1, 2000 | 2012 | 2000 |
| Machine learning identifies stemness features associated with oncogenic dedifferentiation TM Malta, A Sokolov, AJ Gentles, T Burzykowski, L Poisson, JN Weinstein, ... Cell 173 (2), 338-354. e15, 2018 | 1723 | 2018 |
| Systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy V Ficarra, G Novara, RC Rosen, W Artibani, PR Carroll, A Costello, ... European urology 62 (3), 405-417, 2012 | 1343 | 2012 |
| Time trends and local variation in primary treatment of localized prostate cancer MR Cooperberg, JM Broering, PR Carroll Journal of Clinical Oncology 28 (7), 1117-1123, 2010 | 1151 | 2010 |
| Overdiagnosis and overtreatment of prostate cancer S Loeb, MA Bjurlin, J Nicholson, TL Tammela, DF Penson, HB Carter, ... European urology 65 (6), 1046-1055, 2014 | 1081 | 2014 |
| Genomic and molecular landscape of DNA damage repair deficiency across the cancer genome atlas TA Knijnenburg, L Wang, MT Zimmermann, N Chambwe, GF Gao, ... Cell reports 23 (1), 239-254. e6, 2018 | 968 | 2018 |
| Genomic and functional approaches to understanding cancer aneuploidy AM Taylor, J Shih, G Ha, GF Gao, X Zhang, AC Berger, SE Schumacher, ... Cancer cell 33 (4), 676-689. e3, 2018 | 944 | 2018 |
| Spatial organization and molecular correlation of tumor-infiltrating lymphocytes using deep learning on pathology images J Saltz, R Gupta, L Hou, T Kurc, P Singh, V Nguyen, D Samaras, ... Cell reports 23 (1), 181-193. e7, 2018 | 893 | 2018 |
| Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. J Kurhanewicz, DB Vigneron, H Hricak, P Narayan, P Carroll, SJ Nelson Radiology 198 (3), 795-805, 1996 | 879 | 1996 |
| The cancer genome atlas comprehensive molecular characterization of renal cell carcinoma CJ Ricketts, AA De Cubas, H Fan, CC Smith, M Lang, E Reznik, R Bowlby, ... Cell reports 23 (1), 313-326. e5, 2018 | 876 | 2018 |
| The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after … MR Cooperberg, DJ Pasta, EP Elkin, MS Litwin, DM Latini, J Du Chane, ... The Journal of urology 173 (6), 1938-1942, 2005 | 853 | 2005 |
| Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging—clinicopathologic study J Scheidler, H Hricak, DB Vigneron, KK Yu, DL Sokolov, LR Huang, ... Radiology 213 (2), 473-480, 1999 | 794 | 1999 |
| Comprehensive analysis of alternative splicing across tumors from 8,705 patients A Kahles, KV Lehmann, NC Toussaint, M Hüser, SG Stark, ... Cancer cell 34 (2), 211-224. e6, 2018 | 774 | 2018 |
| A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling EA Klein, MR Cooperberg, C Magi-Galluzzi, JP Simko, SM Falzarano, ... European urology 66 (3), 550-560, 2014 | 742 | 2014 |
